Armistice Capital, Llc Achieve Life Sciences, Inc. (ACHV) insider trading activity

Armistice Capital, LLC is > 10% Shareholder of ACHIEVE LIFE SCIENCES, INC.. Currently has a direct ownership of 843,776 shares of ACHV, which is worth approximately $3.69 Million. The most recent transaction as insider was on Jun 11, 2019, when has been sold 264,963 shares (Common Stock) at a price of $3.25 per share, resulting in proceeds of $861,130. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 844K

0% 3M change

0% 12M change

Total Value Held $3.69 Million

ARMISTICE CAPITAL, LLC Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 11 2019	SELL Open market or private sale	$861,130 $3.25 p/Share	264,963 Reduced 23.9%	843,776 Common Stock
Jun 11 2019	SELL Open market or private sale	$138,243 $2.93 p/Share	47,182 Reduced 5.59%	796,594 Common Stock
Jun 11 2019	BUY Open market or private purchase	$48,689 $3.8 p/Share	12,813 Added 1.23%	1,026,000 Common Stock

Also insider at

SAVA

CASSAVA SCIENCES INC Healthcare

> 10% Shareholder

VXRT

Vaxart, Inc. Healthcare

Director

AVTX

Avalo Therapeutics, Inc. Healthcare

> 10% Shareholder

ALIM

ALIMERA SCIENCES INC Healthcare

> 10% Shareholder

BPTH

BIO-PATH HOLDINGS INC Healthcare

> 10% Shareholder

ONTX

Onconova Therapeutics, Inc. Healthcare

> 10% Shareholder

AYTU

AYTU BIOPHARMA, INC Healthcare

Director

CYTH

Cyclo Therapeutics, Inc. Healthcare

> 10% Shareholder

BBI

Brickell Biotech, Inc. Healthcare

> 10% Shareholder

RSLS

ReShape Lifesciences Inc. Healthcare

> 10% Shareholder

TENX

TENAX THERAPEUTICS, INC. Healthcare

Director

KPRX

KIORA PHARMACEUTICALS INC Healthcare

> 10% Shareholder

TTPH

TETRAPHASE PHARMACEUTICALS INC

Director

AMAG

AMAG PHARMACEUTICALS, INC.

> 10% Shareholder

VLRX

Valeritas Holdings Inc.

> 10% Shareholder

DFRG

Del Frisco's Restaurant Group, Inc.

> 10% Shareholder

RSLS

ReShape Weightloss Inc.

> 10% Shareholder

INNV

INNOVUS PHARMACEUTICALS, INC.

> 10% Shareholder

ACL